Jan 13, 2025 07:00AM

Jan 1, 2025 08:46AM

Dec 16, 2024 12:01PM

Nov 15, 2024 07:27PM

Aug 12, 2024 07:00AM

Jun 7, 2024 07:27AM

May 30, 2024 07:00AM Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

May 4, 2024 08:00AM

Apr 17, 2024 07:00AM

Apr 15, 2024 07:41AM

Apr 12, 2024 07:49PM

Mar 20, 2024 07:00AM

Mar 8, 2024 07:00AM

Mar 7, 2024 06:00AM MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

Dec 15, 2023 10:26AM

Dec 13, 2023 07:00AM

Nov 29, 2023 05:00PM

Oct 3, 2023 07:00AM

Sep 19, 2023 07:00AM

Jul 17, 2023 04:01PM

Jun 15, 2023 07:00AM Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

May 30, 2023 07:00AM

May 25, 2023 07:00AM

Jun 10, 2022 07:30PM

Jan 19, 2022 08:00AM

Nov 10, 2021 05:00AM

Jul 12, 2021 08:00AM

Jun 17, 2021 07:00AM Ketamine One Highlights Psychedelic Research and Announces New Clinical Trial

Dec 2, 2020 08:00AM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All